National Psoriasis Foundation

Phototherapy has been used to treat psoriasis for over 100 years; however, access to this treatment remains challenging. The LITE study is working to change that. Head to our website to read the results from this study and what it means for the future of psoriatic disease treatment 🔗https://lnkd.in/gV5Wzj_Y

Meet Larry Bahr, a longtime NPF volunteer and advocate! Larry's psoriasis journey began in 1979 and led him to become a passionate voice for the community impacted by psoriatic disease. #NPFAdvocacy Read more of Larry's story on our website! ➡️ https://lnkd.in/gYH4S_Kq

We are thrilled to announce the 2024 NPF Research Grant and Fellowship Award recipients! These awards highlight NPF’s unwavering commitment to curing psoriatic disease and improving the health of everyone affected. By funding groundbreaking research and supporting talented investigators, we continue to lead the way in psoriatic disease and psoriasis comorbidities research. Congratulations to all the awardees, and thank you to our dedicated community and partners! Together, we are moving closer to a life free of psoriatic disease. Read the full press release on our website ➡️https://lnkd.in/gBhiPRCk

Last week's IFPA conference celebrations wouldn't be complete without pausing to honor Kathleen Gallant, National Psoriasis Foundation emeritus Director and IFPA Board Member. Kathleen was the "chief architect" (h/t Josef De Guzman for this title!) behind the World Health Organization Psoriasis Resolution 10 years ago. Her dedication and expertise have been instrumental in navigating the complexities of international health policy, drawing much-needed attention to psoriatic disease. Kathleen spoke about the profound impact of the resolution a decade later at the 7th IFPA Psoriasis & Psoriatic Arthritis Conference in Stockholm. Her unwavering commitment continues to inspire the international psoriatic disease community to boldly move our agenda forward. We owe a tremendous debt of gratitude to Kathleen and were privileged to celebrate this milestone with her and the psoriasis community. Thank you, Kathleen, for your relentless advocacy and for making a lasting difference in the lives of those affected by psoriatic disease. 🌍❤️ #PsoriasisAwareness #Advocacy #ThankYouKathleen #IFPAConference #NPF (A few photos of more than a decade of advocacy with Kathleen on this resolution and celebrating the 10 year milestone last week!)

Calling all #rheumatologists 📅 Save the date for the annual Dermatology Residents' and Rheumatology Fellows' Meeting on October 19-20 in Salt Lake City! This prestigious event offers an opportunity to advance your knowledge in the latest treatments and management of psoriasis and psoriatic arthritis. Enhance your expertise and collaborate with dermatology residents in this unique cross-disciplinary training experience. Don't miss out—apply now to elevate your practice and improve patient care! ➡️ https://lnkd.in/gQTuGA6R

What an engaging three days in Stockholm at the 7th World Psoriasis & Psoriatic Conference hosted by IFPA chaired by Dr. April Armstrong, MD MPH! It was fascinating to listen to experts unpack topics from #treatment advances to unmet needs to the #prevention of psoriatic arthritis from a global vantage point. I had the honor of highlighting the work of the National Psoriasis Foundation and the complexities of accessing care in the U.S. through two panels: "From diagnosis to treatment: Rethinking care to better meet patient needs" (presented by Bristol Myers Squibb) and "Beyond the surface: a deep dive into the psoriatic disease spectrum." These sessions included a look at data from NPF’s Health Indicator Report - recently released as part of our work under the Centers for Disease Control and Prevention Chronic Disease Education & Awareness Grant - and impactful research funded by the NPF including the CP3 grant with the potential to change and extend lives! Today, the focus shifts to the IFPA patient organization member meeting. Excited to continue learning, sharing, and collaborating in this dynamic environment. #Psoriasis #IFPA #PatientCare #MedicalConference

Today, we unveil our bold 5-year Strategic Plan, setting the stage for groundbreaking advancements in our mission to cure psoriatic disease and optimize health for those affected. With a focus on expanding research, enhancing clinical care, and improving access to life-changing therapies, we're committed to making sure everyone receives the care and cure they deserve. Together with our dedicated community of stakeholders, including healthcare providers, researchers, and advocates, we're committed to finding a cure for psoriatic disease and improving the lives of those affected. Read the full Strategic Plan: https://lnkd.in/gYE5cqu6

We spent the weekend in the windy city at our Collaborative Care in Psoriatic Disease. This dynamic panel of clinicians underscored the essential role of interdisciplinary collaboration in managing psoriatic disease. A sincere thank you to our co chairs, Dr. Jennifer Soung and Dr. G. Michael Lewitt for their outstanding leadership in organizing such a transformative event, and to all those who brought their invaluable expertise to this event. Don't miss an NPF event in your area: psoriasis.org/events

We are pleased to announce Kenkoderm products have earned our coveted Seal of Recognition. Products that have earned the NPF Seal of Recognition have gone through an application, evaluation, and approval process, which includes submitting independently tested scientific data demonstrating the product does not irritate skin and or joints burdened with psoriasis, psoriatic arthritis, sensitive skin, or joint mobility limitations. Check out our website to find all the products that carry the NPF Seal of Recognition. https://lnkd.in/gstytWYb

Join us in honoring the legacy of IFPA president, Dr. Hoseah Waweru, whose unwavering dedication and compassion deeply impacted the global psoriatic disease community. His leadership, kindness, and wisdom will be greatly missed, but his spirit will continue to guide us in our fight for a world free of psoriatic disease. Our heartfelt condolences go out to his family and friends during this difficult time. As a community, we echo the sentiments of our board member Kathleen Gallant (pictured below) : 'Hoseah was gentle, kind and at the same time a pillar of granite of the global psoriatic disease community. He was much loved and respected.' IFPA's full statement: https://lnkd.in/gqe9vmN9